The Promise and Reality of Next Generation Therapies
Play • 41 min

Our Transformation Talks Summer Special is here!

Tune in to learn about risks and challenges in developing a Next-Generation Therapy (NGT), bringing it to the market, and how NGTs can change patients’ lives once their value is understood and correctly attributed by the decision makers / payers.

Meet our speakers:

  • Andrea Mantovani Vice President, Global Market Access and Pricing, Alira Health
  • Oswald Bentinck - Vice President - Head of Market Access EMEA, Novartis Gene Therapies
  • Pietro Sternini - Executive Director, Gene Therapy Market Access & Marketing Lead, EMEA, Astellas Gene Therapies

Meet our host:

Kenny CarberryDirector, Clinical Development, Alira Health

This episode is also available in video format, check it out on our YouTube channel:

Download this episode's handouts here.

More episodes
Clear search
Close search
Google apps
Main menu